KOSDAQElectronic Components006140

PJ Electronics

₩4,495▲ 0.90%2026-11-18 close
Market Cap
₩66.8B
Turnover
₩77,704,065
Volume
20K
Shares out.
14.9M
PER
7.2×
PBR
0.5×
EPS
₩630
Dividend Yield
4.38%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩200 per share · Prices as of the 2026-11-18 close

01

Report overview

Revenue Rising, but Quarterly Operating Profit Down Three Straight Quarters

PJ Electronics grew revenue for three straight years through 2025, but quarterly operating profit has declined since its fourth-quarter 2025 peak, and third-quarter 2026 net profit attributable to controlling shareholders fell to KRW 122 million.

  1. 1

    Revenue reached KRW 178.6 billion in 2025, up from KRW 157.7 billion in 2022, and rose for three consecutive years from 2023 through 2025.

  2. 2

    Operating profit was KRW 11 billion in 2025, and the operating margin slipped to 6.1% from 6.4% in 2024. Operating profit rose 1.7% against a 5.5% revenue increase.

  3. 3

    Net profit attributable to controlling shareholders was KRW 122 million in the third quarter of 2026, down 95.0% year on year, while operating profit was KRW 1.73 billion.

  4. 4

    The business is concentrated in ultrasound diagnostic equipment and related products, with the company widening its scope into automotive electronics and robot controllers.

  5. 5

    Shareholders approved a cash dividend at the March 2026 general meeting, and a retirement of 135,000 treasury shares was recorded in the capital change history that year.

02

Business structure

PJ Electronics is an EMS-style electronics manufacturer. As of March 2026, its sales mix was 93% ultrasound diagnostic equipment and other products, 5% SMD, and 2% rental income.

The company began by specializing in ultrasound diagnostic devices sold by GE and Siemens at home and abroad, and it has since expanded into robot-related work with Hyundai Robotics, Hyundai Motor and Kia's tier-2 suppliers, and automotive electronics.

By product, ultrasound diagnostic devices were 81% exported in 2025, while automotive electronic parts were 97.3% domestic and robot controllers were 100% domestic. Overall, 2025 sales were 36% domestic and 64% export.

Management says it won more orders for higher-difficulty products such as ultrasound devices, security devices and GPS modules, supported by its high-function SMD line. Rental operations across seven regions supplement manufacturing income.

Based on 2025 annual sales, the company ranked 10th among 97 companies in the medical equipment and supplies sector. In the broader electronics and components sector, large peers such as Samsung Electro-Mechanics, LG Innotek and Isupetasys operate with different product scope and scale.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩45.4B₩2.4B5.4%
2025Q4₩48.6B₩2.8B5.7%
2026Q1₩51.1B₩1.8B3.6%
2026Q2₩50.7B₩1.8B3.5%
2026Q3₩49.6B₩1.7B3.5%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩157.7B₩6.1B₩7B3.9%5.8%53.9%
2023₩166.8B₩7.4B₩6.1B4.4%4.9%49.0%
2024₩169.3B₩10.8B₩9.2B6.4%6.9%44.6%
2025₩178.6B₩11B₩9.4B6.1%6.7%42.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

On a disclosed annual basis, revenue rose from KRW 157.7 billion in 2022 to KRW 166.8 billion in 2023 (up 5.8%), KRW 169.3 billion in 2024 (up 1.5%) and KRW 178.6 billion in 2025 (up 5.5%), with 2025 the largest year of 2022 to 2025.

Operating profit went from KRW 6.09 billion in 2022 to KRW 7.41 billion in 2023 (up 21.7%), KRW 10.8 billion in 2024 (up 45.4%) and KRW 11 billion in 2025 (up 1.7%), rising for three consecutive years from 2023 through 2025.

The operating margin climbed from 3.9% in 2022 to 4.4% in 2023 and 6.4% in 2024, then eased to 6.1% in 2025, as revenue growth outpaced operating profit growth.

Net profit attributable to controlling shareholders fell from KRW 6.96 billion in 2022 to KRW 6.11 billion in 2023 (down 12.2%), then rose to KRW 9.22 billion in 2024 (up 50.9%) and KRW 9.35 billion in 2025 (up 1.4%), growing two years in a row.

In 2023 operating profit rose while net profit fell, and non-operating income forms a meaningful part of the earnings structure. Operating cash flow grew from KRW 1.14 billion in 2022 and KRW 3.46 billion in 2023 to KRW 21.2 billion in 2024 and KRW 26.9 billion in 2025.

Quarterly revenue went from KRW 45.4 billion in the third quarter of 2025 to KRW 48.6 billion in the fourth quarter (up 7.1% quarter on quarter) and KRW 51.1 billion in the first quarter of 2026 (up 5.1%), then slipped to KRW 50.7 billion and KRW 49.6 billion, down for two straight quarters.

Operating profit peaked at KRW 2.77 billion in the fourth quarter of 2025, then fell to KRW 1.82 billion in the first quarter of 2026 (down 34.1%), KRW 1.76 billion in the second quarter and KRW 1.73 billion in the third quarter (down 29.0% year on year), a three-quarter decline.

Net profit attributable to controlling shareholders fell from KRW 3.84 billion in the first quarter of 2026 to KRW 1.84 billion in the second quarter (down 52.0%) and KRW 122 million in the third quarter (down 93.4%), and the last four quarters total KRW 9.38 billion.

Past press coverage linked margin gains to automotive electronics and higher-spec model production, so the recent margin decline should be read alongside volume and mix changes.

05

Industry analysis

Demand in the downstream market is shaped by the expansion of electric and autonomous vehicles, which is expected to grow automotive electronics, and by factory automation and smart-factory adoption, which is expected to lift demand for robot controllers. A company summary cites this trend as a basis for growth.

Ultrasound diagnostic devices depend on overseas medical equipment demand, and 81% of this product line was exported in 2025. Automotive electronic parts were 97.3% domestic in 2025, which points to dependence on domestic customers' vehicle and parts production.

Competitively, the company operates as an EMS-style contract manufacturer, unlike the large component makers in the broader electronics sector, and it ranked in the top tier of the medical equipment sector by 2025 annual sales.

Quarterly revenue has fallen for two straight quarters since its first-quarter 2026 peak, so customer volume changes are the item to monitor. Management has said margins vary with the mix of customer models. Short-term earnings therefore appear more sensitive to model mix and volume flow than to the sector cycle. This structure could change as automotive and robot controller revenue grows as a share of the total.

06

Outlook

The company's next regular report is the 2026 annual report, which will be the first to show fourth-quarter 2026 and full-year totals. Whether the operating profit decline that continued through the third quarter also carried into the fourth quarter is the point to check.

Expansion of electric and autonomous vehicles and demand for robot controllers have been cited as medium- to long-term demand drivers. At the general meeting on March 24, 2026, the 57th financial statements were approved and a cash dividend was resolved.

The retirement of 135,000 treasury shares decided that same year was recorded in the capital change history with a listing date of May 4, 2026, showing that shareholder returns are also reflected in the capital structure.

Whether the non-ultrasound portion of the sales mix grows will be visible in the segment composition of the next regular report. With 64% of 2025 sales exported, overseas demand and exchange rates also affect operating profit. The operating margin in the next regular report is the next checkpoint.

Third-quarter 2026 operating profit of KRW 1.73 billion on KRW 49.6 billion in revenue left the margin at a low level, so whether the fourth quarter recovers is the key variable.

07

Valuation

PER
7.2×
PBR
0.5×
ROE
6.7%
EPS
₩630
BPS
₩9,563
Dividend per share
₩200

Based on year-end figures, the PER ranged from about 19.7 times at the end of 2020 and 14.4 times at the end of 2021, to 12.1 times at the end of 2022 and 16.5 times at the end of 2023, before falling to about 7.3 times at the end of 2024, so the multiple moved widely with earnings.

Over the same period, the price-to-book ratio ranged from about 0.5 to 1.0 times. The current multiple sits at the lower end of that band, and the price-to-book ratio is near the low end of its year-end range, meaning the stock trades without a premium to net assets.

The dividend yield ranks in the upper tier of the medical equipment and supplies sector in Alphasquare's data.

Because the multiple depends directly on earnings, the 2025 annual net profit attributable to controlling shareholders of KRW 9.35 billion and the four-quarter total of KRW 9.38 billion being at similar levels links the multiple to a steady earnings base.

However, the third-quarter 2026 drop to KRW 122 million means the same share price can imply a different multiple depending on whether quarterly profit recovers. The earnings recovery from the 2023 low through 2024 and 2025 is the reference point for interpreting the multiple.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Wider Scope in Automotive and Robot Controllers

Automotive electronic parts and robot controllers were 97.3% and 100% domestic in 2025, giving the company a domestic customer base in these lines. A company summary expects automotive electronics to grow with electric and autonomous vehicles, and robot controller demand to rise with factory automation. If these lines grow as a share of sales, dependence on ultrasound devices would decline.

Shareholder Return Decisions Executed

PJ Electronics disclosed on March 24, 2026 that its general meeting approved the 57th financial statements and a cash dividend, among other items. A retirement of 135,000 treasury shares that year was recorded in the capital change history, so dividends and capital reduction were both carried out.

Whether these returns continue regardless of earnings swings will be confirmed by future general meeting decisions.

Improving Financial Strength

The debt ratio fell from 53.9% in 2022 to 49.0% in 2023, 44.6% in 2024 and 42.1% in 2025. Total equity stood at KRW 139.4 billion and total liabilities at KRW 58.7 billion at the end of 2025.

Operating cash flow reached KRW 21.2 billion in 2024 and KRW 26.9 billion in 2025, a level well above the net profit figures for those years.

09

Bear factors

Consecutive Quarterly Profit Declines

Operating profit has declined for three straight quarters, from KRW 2.77 billion in the fourth quarter of 2025 to KRW 1.73 billion in the third quarter of 2026. Net profit attributable to controlling shareholders fell to KRW 122 million in the third quarter of 2026, down 95.0% year on year.

Revenue has also declined for two straight quarters since its first-quarter 2026 peak, so the profit decline and the sales decline are happening together.

Revenue Concentrated in Ultrasound Equipment

As of March 2026, ultrasound diagnostic equipment and other products accounted for 93% of sales, SMD for 5% and rental income for 2%. Ultrasound devices were 81% exported in 2025, so revenue depends on overseas demand and external conditions.

Automotive and robot controller lines are not yet large enough in total sales to deliver a major diversification effect.

Margin and Net Profit Not Moving Together

The operating margin slipped to 6.1% in 2025 from 6.4% in 2024. In 2023 operating profit rose to KRW 7.41 billion, yet net profit attributable to controlling shareholders fell 12.2% to KRW 6.11 billion. This shows that swings in non-operating items can affect net profit independently of operating results.

10

Risk factors

Customer and Product Concentration

Most sales come from ultrasound equipment and related products, so volume changes in a single product line flow directly into company-wide results. A 64% export share makes results sensitive to overseas customer orders.

The company's own explanation that margins vary with customer model mix shows how much its profitability depends on individual customers.

Earnings Volatility and Non-Operating Items

Net profit attributable to controlling shareholders swung from KRW 3.84 billion in the first quarter of 2026 to KRW 122 million in the third quarter, a sharp quarterly range. Non-operating income accounts for a meaningful part of the earnings structure, so net profit can move even when operating profit is stable. In 2023, operating profit and net profit moved in opposite directions.

Exchange Rates and Overseas Demand

Exports made up 64% of 2025 sales, so exchange rate movements affect won-denominated revenue and profit. A slowdown in overseas demand for medical equipment could reduce volumes in the export-heavy product lines. Exchange rates and overseas order flows are external variables the company cannot control.

11

What to watch next

  1. Around March 2027

    The 2026 annual report will be the first disclosure of fourth-quarter 2026 revenue and operating profit and full-year totals. Whether the operating profit decline seen through the third quarter continued into the fourth quarter is the key point.

  2. Around March 2027

    The general meeting is expected to resolve dividend and capital matters. It will show whether shareholder returns decided at the March 2026 meeting are repeated and whether dividend levels hold during the earnings decline.

  3. Around May 15, 2027

    The first-quarter 2027 quarterly report is due around this date. It will show whether operating profit recovers from the KRW 1.73 billion level of the third quarter of 2026 and whether revenue rises above KRW 49.6 billion.

  4. Around August 2027

    The 2027 half-year report will show first-half results and the operating margin. Whether automotive electronics and robot controllers grow as a share of total sales can also be checked in its segment breakdown.

12

Overall view

PJ Electronics recorded three consecutive years of higher revenue and operating profit from 2023 through 2025, with 2025 operating profit of KRW 11 billion and net profit attributable to controlling shareholders of KRW 9.35 billion.

However, operating profit and revenue have declined since the fourth quarter of 2025, and net profit attributable to controlling shareholders fell to KRW 122 million in the third quarter of 2026.

Ultrasound diagnostic equipment and related products make up 93% of sales and 64% of 2025 sales were exported, so the business depends on a few products and overseas demand. Automotive electronics and robot controllers are domestic-focused lines that have been cited as growth areas.

Shareholder returns were also carried out, with a dividend and a treasury share retirement approved in 2026. The debt ratio fell to 42.1% in 2025 and operating cash flow rose to KRW 26.9 billion.

On valuation, the multiple sits at the lower end of its year-end PER and price-to-book ranges, and the dividend yield ranks in the upper tier of its sector. How the multiple is read depends on whether quarterly profit recovers.

The next checkpoints are the fourth-quarter results in the 2026 annual report and quarterly operating profit in the first quarter of 2027.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 13 more articles and sources
  1. comp.fnguide.com
  2. jobkorea.co.kr
  3. alphasquare.co.kr
  4. comp.fnguide.com
  5. m.catch.co.kr
  6. komachine.com
  7. comp.fnguide.com
  8. etoday.co.kr
  9. m.news.nate.com
  10. job-post.co.kr
  11. investing.com
  12. asiae.co.kr
  13. judal.co.kr

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis